Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases

Auto- Immunity Highlights
Cecilia NalliAngela Tincani

Abstract

Anti-phospholipid antibodies (aPL) analyzed by line immunoassay (LIA) can recognize beta2-glycoprotein I (β2GPI) domain 1 (D1) epitopes depending on β2GPI binding to distinct phospholipids. The aPL LIA was compared with consensus ELISA to investigate whether both techniques can discriminate anti-phospholipid syndrome (APS) patients from aPL-positive, systemic autoimmune rheumatic diseases (SARD) patients without clinical symptoms of APS and controls. Thirty-four APS patients (14 arterial/venous thrombosis, 16 pregnancy morbidity, and 4 both), 41 patients with SARD lacking clinical APS criteria but demonstrating positivity for anti-β2GPI (aβ2GPI) IgG, and 20 healthy subjects (HS) were tested for aPL to cardiolipin (aCL), phosphatidic acid, phosphatidylcholine, phosphatidylethanolamine, phosphatidylglycerol (aPG), phosphatidylinositol, phosphatidylserine, β2GPI, prothrombin, and annexin V by LIA. Samples were also tested for aCL, aβ2GPI, aβ2GPI-domain 1 (aD1), and aβ2GPI-domains 4-5 (aD4-5) by ELISA and for lupus anti-coagulant. Comparison of LIA with ELISA revealed a good agreement for the consensus criteria aPL aβ2GPI and aCL IgG (kappa = 0.69, 0.68, respectively) and a moderate agreement for IgM (kappa = 0.52, 0.49, respective...Continue Reading

References

Aug 2, 2003·Lupus·R A AshersonUNKNOWN Catastrophic Antiphospholipid Syndrome Registry Project Group
Jun 22, 2005·Thrombosis and Haemostasis·Vittorio PengoSabino Iliceto
Sep 9, 2010·Lancet·Guillermo Ruiz-IrastorzaMunther A Khamashta
May 11, 2011·Nature Reviews. Rheumatology·Pier Luigi MeroniFrancesco Tedesco
Jul 23, 2011·Arthritis Research & Therapy·Karl EgererThomas Dörner
Sep 26, 2012·Autoimmunity Reviews·Dirk RoggenbuckThomas Dörner
Oct 3, 2012·Thrombosis Research·V Pengo
Dec 12, 2012·Autoimmunity Reviews·V PengoA Ruffatti
Nov 28, 2013·Nature Reviews. Rheumatology·Pier Luigi MeroniMaria Orietta Borghi
Mar 5, 2014·Journal of Thrombosis and Haemostasis : JTH·K M J DevreeseUNKNOWN Subcommittee on Lupus Anticoagulant/Phospholipid/Dependent Antibodies
Sep 18, 2014·Lupus·D RoggenbuckP L Meroni
May 4, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Lauro MeneghelPaolo Simioni
Jun 16, 2015·Journal of Immunology Research·Cecilia Beatrice ChighizolaPier Luigi Meroni
Jul 18, 2015·Journal of Immunology Research·Christoph FickentscherMartin Herrmann
Mar 12, 2016·Biochimica Et Biophysica Acta·Murugappan Sathappa, Nathan N Alder
Jun 28, 2016·Clinica Chimica Acta; International Journal of Clinical Chemistry·Anne E TeboD Ware Branch

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA
ELISAs
enzyme-linked immunosorbent assays

Software Mentioned

Medcalc

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.